Hematopoietic stem and progenitor cell niche (HSPC niche)

The hematopoietic stem and progenitor cell (HSPC) niche is a specialized microenvironment within the bone marrow that regulates the survival, self-renewal, and differentiation of blood-forming stem cells. It is composed of a diverse array of cellular components, including osteoblasts, endothelial cells, and mesenchymal stromal cells, which interact with HSPCs through physical contact and secreted factors like CXCL12 and Stem Cell Factor (Morrison & Scadden, 2014). This niche plays a critical role in maintaining blood homeostasis and responding to hematological stress or injury. In the context of disease, the niche can be altered to support the growth of leukemic cells or can become dysfunctional in bone marrow failure syndromes (Lane et al., 2014). Therapeutic interventions often target the niche to facilitate stem cell transplantation or to disrupt the protective environment that shields cancer cells from treatment. Because it represents a complex cellular system rather than a single molecular entity, it is generally categorized as a therapeutic environment rather than a discrete drug target.

Other names

Hematopoietic stem cell nicheBone marrow nicheHSPC microenvironmentHematopoietic progenitor and niche cellsStem cell niche

Pharmacological agents typically target specific molecular axes within the niche, such as the CXCR4/CXCL12 interaction, to induce the mobilization of hematopoietic progenitor cells from the bone marrow into the peripheral circulation (Lapidot & Petit, 2002). Other agents, like G-CSF, stimulate the release of proteases that cleave anchoring molecules like VCAM-1 and SCF, further facilitating cell release.